Orthofix Medical Inc.·4

May 29, 4:57 PM ET

MICHAS ALEXIS P 4

Research Summary

AI-generated summary

Updated

Orthofix (OFIX) 10% Owner Juniper Investment Buys 242,000 Shares

What Happened
Juniper Investment Company, LLC — reported as a 10% owner of Orthofix Medical, Inc. (OFIX) — acquired 242,000 shares on May 22, 2026. The filing lists an aggregate value of $2,589,206 and an average price shown as $10.70; a footnote clarifies the weighted average price ranged from $10.2450 to $10.9500 and that the reporting person will provide trade-level details to the issuer or the SEC upon request. This was a purchase (acquisition), not a sale.

Key Details

  • Transaction date: 2026-05-22; reported on Form 4 filed 2026-05-29.
  • Reported aggregate value: $2,589,206; average price shown: $10.70 (footnote F1: actual per‑share prices ranged $10.2450–$10.9500).
  • Shares acquired: 242,000.
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Notable footnotes: F1 (weighted average price range, more details available on request); F2–F4 clarify Juniper Investment is the investment manager of several Juniper funds and may be deemed to beneficially own securities held by those funds but disclaims beneficial ownership except to the extent of its pecuniary interest; managing members John A. Bartholdson and Alexis P. Michas share voting and dispositive power and similarly disclaim beneficial ownership except to their pecuniary interest.
  • Filing timeliness: The Form 4 was filed seven days after the transaction (May 29 for a May 22 trade), which is later than the usual two-business-day Form 4 deadline.

Context

  • This is institutional activity by a 10% owner/investment manager, not an executive officer or director trade. Institutional purchases indicate investment activity by a fund manager but do not equate to insider knowledge or a company executive’s personal view.
  • The filing’s footnotes emphasize the manager/fund relationship and disclaimers of beneficial ownership; treat the reported acquisition as a fund-level position change rather than a personal purchase by company insiders.